PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors
BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Howard Mayer, M.D. to the PepGen Board of Directors, effective November 15, 2023.
Related news for (PEPG)
- 24/7 Market News Snapshot 25 September, 2025 – PepGen Inc. Common Stock (NASDAQ:PEPG)
- PepGen Announces Pricing of $100 Million Public Offering
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/25/25 07:00 AM
- Today’s Top Performers: MoBot’s Market Review 09/25/25 06:00 AM
- MoBot alert highlights: NASDAQ: OFAL, NASDAQ: PEPG, NASDAQ: XXII, NYSE: LAC, NYSE: ATCH (09/25/25 05:00 AM)